Roche CEO criticizes TV advertising

Share this article:
Consumer advertising “was the single worst decision for the industry,” according to Roche Pharmaceuticals CEO William Burns at a conference in London early last month.

Burns cast doubt on industry claims that R&D spending far outpaces ad spend, saying: “When industry says we're spending all the money on R&D but actually it's spending it on TV advertising to preserve margins, it doesn't get much credibility.” Burns' stinging remarks, made at a Financial Times conference, were reported by Reuters. 

His condemnation of consumer advertising was echoed by Shire CEO Angus Russell.

Burns went on to lambaste the marketing of me-too drugs, saying “the marginally-different-and-market-it-like-hell model is over,” but called for a liberalization of strict limits on consumer communication in Europe. 

“You've got two extremes on the planet,” said Burns, “where we are given access to the public in America, which is too much, and in Europe we're not given access to information.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?